De novo and relapsing glomerulonephritis after COVID-19 vaccination: how much do we know?

Chan, Anthony T P; Tang, Sydney C W

Chan, Anthony T P; Tang, Sydney C W.

Chan ATP; Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Tang SCW; Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.

Nephrology (Carlton) ; 27(1): 5-6, 2022 Jan.

Article in English | MEDLINE | ID: covidwho-1583471

Subject(s)

COVID-19 Vaccines/adverse effects; COVID-19/prevention & control; Glomerulonephritis/etiology; SARS-CoV-2/immunology; Vaccination/adverse effects; COVID-19/virology; Global Health; Glomerulonephritis/epidemiology; Humans; Incidence; Recurrence

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Glomerulonephritis Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Nephrology (Carlton) Journal subject: Nephrology Year: 2022 Document Type: Article Affiliation country: Nep.14013

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google